TAmiRNA — microRNA & cfRNA Biomarker Solutions

TAmiRNA is a Vienna‑based biotechnology company specialising in microRNA and cfRNA biomarkers for precision medicine, with a strong focus on aging‑related and chronic diseases.

Its technologies enable sensitive analysis of circulating RNA from liquid biopsies, supporting diagnostic, monitoring and therapeutic development applications.

What TAmiRNA does

• microRNA biomarker discovery & validation in blood and other biofluids

• High‑sensitivity RNA profiling using qPCR and adapted NGS workflows

• Development of cfRNA diagnostic signatures, including senomiR®, osteomiR®, thrombomiR®, and hepatomiR® (CE‑IVD)

• Comprehensive RNA analysis services for research and development projects

Who they serve

• Pharmaceutical & biotech companies developing RNA‑based biomarkers or targeted therapies

• Academic & clinical research centres working on metabolic, cardiovascular, musculoskeletal, liver and aging‑related diseases

• Diagnostic laboratories seeking minimally invasive microRNA/cfRNA testing solutions

Why TAmiRNA

• Deep expertise in circulating microRNA and cfRNA

• Strong translational focus, from discovery to validated diagnostic signatures

• Advanced analytical platforms combining LNA‑qPCR, NGS and proprietary algorithms

• Proven collaboration in European R&D programmes and industry–academia partnerships

More information: tamirna.com